Article info
Clinical science
Outcomes of persistently active neovascular age-related macular degeneration treated with VEGF inhibitors: observational study data
- Correspondence to Professor Mark Gillies, Save Sight Institute, South Block, 8 Macquarie St., Sydney, NSW 2001, Australia; mark.gillies{at}sydney.edu.au
Citation
Outcomes of persistently active neovascular age-related macular degeneration treated with VEGF inhibitors: observational study data
Publication history
- Received May 9, 2014
- Accepted August 16, 2014
- First published September 23, 2014.
Online issue publication
March 22, 2016
Article Versions
- Previous version (22 March 2016).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions